🇺🇸 Doxicycline in United States
70 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 70
Most-reported reactions
- Dyspnoea — 8 reports (11.43%)
- Off Label Use — 8 reports (11.43%)
- Pneumonia — 8 reports (11.43%)
- Asthenia — 7 reports (10%)
- Diarrhoea — 7 reports (10%)
- Nausea — 7 reports (10%)
- Renal Failure — 7 reports (10%)
- Acute Kidney Injury — 6 reports (8.57%)
- Chronic Kidney Disease — 6 reports (8.57%)
- Dizziness — 6 reports (8.57%)
Other Other approved in United States
Frequently asked questions
Is Doxicycline approved in United States?
Doxicycline does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Doxicycline in United States?
Sherief Abd-Elsalam is the originator. The local marketing authorisation holder may differ — check the official source linked above.